ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$288.06
Tradestie Score
60
Market Cap
$60.38B
P/E Ratio
75.3
Revenue Growth
1.0%
Analyst Upside
+53.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$663.09
|
$63.59B | 16.2 | 64 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$876.25
|
$46.96B | 38.9 | 56 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$303.96
|
$36.81B | 67.6 | 54 | Compare |
|
INSM
Insmed, Inc.
|
$109.14
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$90.07
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.80
|
$19.56B | 22.1 | 59 | Compare |
|
INCY
Incyte Genomics Inc
|
$114.23
|
$16.93B | 16.5 | 57 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$56.45
|
$15.70B | 29.7 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.30
|
$15.22B | - | 53 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$174.10
|
$13.59B | 27.2 | 67 | Compare |
More ALNY Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry